Enzo Bonora Salvatore Cataudella Giulio Marchesini RobertoMiccoli Olga Vaccaro Gian P Fadini Nello Martini Elisa Rossi Abstract Background and aims To investigate diabetes treatment initiation and continuation in the next sixth months in newly diagnosed Italian subjects Methods and results We analyzed administrative claims of Italian residents Subjects with incident diabetes were identified by glucose lowering drug prescriptions disease specific co payment exemptions and hospital discharge codes occurring in but not in Incident cases were of whom received the prescription of a glucose lowering drug Among the latter those receiving a prescription of a noninsulin medication but no insulin were those receiving a prescription of insulin only were and those receiving prescriptions of both insulin and noninsulin drugs were Metformin was the most frequently drug initially prescribed in noninsulin treated subjects and sulphonylurea receptor SUR agonists collectively ranked as second Lispro and glargine were the most frequently prescribed molecules in subjects who were insulin treated Differences in prescriptions were found in age categories with increased use of SUR agonists across decades In the first six months as many as of noninsulin treated patients continued with the initial drug added a second agent switched to another medication and discontinued any glucose lowering treatment Conclusions These data document that current guidelines are often neglected because prescriptions of SUR agonists as first agent are still quite common and insulin is prescribed more than expected They point out the urgent need to improve the dissemination and implementations of guidelines in diabetes care Sources 